Cargando…
Adenoviral Vectors for Hemophilia Gene Therapy
Hemophilia is an inherited blood clotting disorder resulting from deficiency of blood coagulation factors. Current standard of care for hemophilia patients is frequent intravenous infusions of the missing coagulation factor. Gene therapy for hemophilia involves the introduction of a normal copy of t...
Autores principales: | Brunetti-Pierri, N, Ng, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039643/ https://www.ncbi.nlm.nih.gov/pubmed/24883229 |
Ejemplares similares
-
Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy
por: Piccolo, Pasquale, et al.
Publicado: (2014) -
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1
por: Castello, Raffaele, et al.
Publicado: (2015) -
Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
por: Vetrini, Francesco, et al.
Publicado: (2010) -
Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022) -
The use of adenoviral vectors in gene therapy and vaccine
approaches
por: Araújo, Natália Meneses, et al.
Publicado: (2022)